Stop SGLT2 Inhibitors When Patients Present With Acute Renal Insufficiency

You'll hear debate over whether SGLT2 inhibitors (Jardiance, etc) harm or help the kidneys in type 2 diabetes patients.

New warnings suggest that canagliflozin (Invokana, etc) and dapagliflozin (Farxiga, etc) can cause acute kidney INJURY. But other evidence suggests the SGLT2 inhibitors, or "flozins," may be PROTECTIVE.

For example, flozins can increase serum creatinine (SCr)...usually within the first month. This is likely due to their diuretic effect...and more common in patients with dehydration, poor renal function, or on an NSAID, diuretic, ACEI, or ARB.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals